Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain.

Open Respir Arch · 2026 · PMC13101690 · PMID 42027629

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

did not reach statistical significancep = 0.051so close (0.05 < p ≤ 0.1)

FEV 1 % increased numerically from 74.9% to 78.9%, but this change did not reach statistical significance ( p = 0.051).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.